Direct and indirect costs of the Norwegian Breast Cancer Screening Program
Norway has had a nationwide, biennial public screening program for breast cancer since 2005. The program includes all women aged 50-69 years. The aim of this study was to estimate the total societal costs of one screening round. The cost analysis was based on the number women in the relevant age group, the proportions attending screening, estimated travel time to nearest mammography facility, and the proportion of women having repeat examination. Unit costs were taken from the DRG price list and other sources. The cost of mobile mammography units were based on cost accounts. The total costs of one screening round were estimated to be NOK 521 million (NOK 1,262 per woman attending screening), of which 64% were health care costs, and 36% were travel costs and productivity losses. The total costs of repeat examinations in one screening round for women with suspicious findings or inadequate quality on the screening mammograms were NOK 52.8 million (NOK 3,655 per woman reexamined). NOK 44.4 million of these costs may be due to false positive findings in the screening mammograms.
|Date of creation:||21 Nov 2012|
|Date of revision:|
|Contact details of provider:|| Postal: |
Phone: 2307 5309
Fax: 2307 5310
Web page: http://www.hero.uio.no/eng.html
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Drummond, Michael F. & Sculpher, Mark J. & Torrance, George W. & O'Brien, Bernie J. & Stoddart, Greg L., 2005. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 3, number 9780198529453, March.
- Godager, Geir, 2009. "Four Empirical Essays on the Market for General Practitioners' Services," HERO On line Working Paper Series 2009:7, Oslo University, Health Economics Research Programme.
- Clarke, Philip M., 1998. "Cost-benefit analysis and mammographic screening: a travel cost approach," Journal of Health Economics, Elsevier, vol. 17(6), pages 767-787, December.
- Philip M. Clarke, 2002. "Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care," Health Economics, John Wiley & Sons, Ltd., vol. 11(2), pages 117-127.
When requesting a correction, please mention this item's handle: RePEc:hhs:oslohe:2012_003. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Anbjørg Kolaas)
If references are entirely missing, you can add them using this form.